News & Updates

The morning home blood pressure (BP) control status seems to influence the association between left ventricular hypertrophy (LVH) and cardiovascular disease (CVD) risk, suggests a study.

Treatment with rivaroxaban appears to improve portal hypertension (PHT)-related complications without increasing the risk of major bleeding in patients with cirrhosis and moderate liver dysfunction, a study has shown.

Lowering the systolic blood pressure (SBP) target to <120 mm Hg compared with <140 mm Hg has a beneficial effect on retinal microvasculature among hypertensive patients with high cardiovascular risk, suggests a recent study.

Individuals with SARS‐CoV‐2 infection, especially those who are hospitalized, face long‐term declines in left ventricular ejection fraction (LVEF), according to a retrospective study.

Older adults with frailty are predisposed to atrial fibrillation (AF)-related hospitalizations, regardless of the presence of multimorbidity, according to a study.

Individuals exposed to brighter lights at night have increased risks of incident coronary artery disease, myocardial infarction, heart failure, atrial fibrillation, and stroke, according to a study.

The reduction in relative risk with intensive vs standard systolic blood pressure (SBP) treatment among individuals without baseline cardiovascular disease (CVD) is consistent across the risk strata using the PREVENT* equations, as shown in the SPRINT study.

Individuals who sustained an acute dengue virus infection are predisposed to cardiovascular events up to 30 days after infection, although the excess risk was modest, according to a study from Singapore.

Timing of surgery appears to influence long-term outcomes in asymptomatic severe mitral regurgitation, such that performing the surgery early leads to better results over the long term than waiting until symptoms develop, according to a study.